Maintenance of skeletal muscle mass during FOLFIRINOX is a favorable prognostic factor in pancreatic cancer patients

OBJECTIVE: The study aimed to investigate the effect of body composition changes during chemotherapy on clinical outcomes in patients with pancreatic cancer. RESULTS: In patients with locally advanced pancreatic cancer (LAPC), the cross-sectional area of skeletal muscle (SM) and adipose tissue (AT)...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Dong Woo, Kim, Minseok Albert, Lee, Jong-chan, Kim, Jaihwan, Hwang, Jin-Hyeok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281692/
https://www.ncbi.nlm.nih.gov/pubmed/34266478
http://dx.doi.org/10.1186/s13104-021-05681-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8281692/
https://www.ncbi.nlm.nih.gov/pubmed/34266478
http://dx.doi.org/10.1186/s13104-021-05681-x

Ejemplares similares